Drugs / 111In-DAC
Trials 2
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT00040560 | — | brain neoplasm, metastatic neoplasm, non-small cell lung carcinoma | Copharos | Unknown | No outcome recorded |
| Phase 1 | NCT00040430 | — | breast cancer | Copharos | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | 111In-DAC | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00040560 ↗ |
| Modality | Diagnostic / imaging agent | “Medical Imaging Agent” NCT00040430 ↗ |